Status:
TERMINATED
Effects of Flourish HEC and BioGenesis to Improve Conception
Lead Sponsor:
Vaginal Biome Science
Conditions:
Infertility
Infertility Unexplained
Eligibility:
FEMALE
18-40 years
Phase:
PHASE1
Brief Summary
This study intends to address whether improving the vaginal microbiome can help couples increase chances of conceiving.
Detailed Description
Disrupted vaginal microbiomes are associated with a number of poor reproductive outcomes, including infertility, miscarriage, premature rupture of membranes, preterm labor and delivery, delivery of a ...
Eligibility Criteria
Inclusion
- Women part of a cisgender couple aged 18 to 40 who are attempting to become pregnant and are attending a fertility clinic.
Exclusion
- Pregnant
- Lactating
- Severe male factor, hormonal imbalance (oligoovulatory/anovulatory cycles, cycles longer than 35 days), genetic abnormalities (chromosomal abnormality, common genetic mutation between partners), or severe uterine or tubal factor
- Any diagnosis that would require the participant to undergo in vitro fertilization to become pregnant
- Known allergies to any component of BioNourish®, Balance, BiopHresh®, or BioGenesis™
- Known active vaginal infection at enrollment
Key Trial Info
Start Date :
June 15 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 20 2023
Estimated Enrollment :
1 Patients enrolled
Trial Details
Trial ID
NCT05390606
Start Date
June 15 2022
End Date
March 20 2023
Last Update
July 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Aimee Eyvazzadeh
San Ramon, California, United States, 94583